Prevalence of Masked Hypertension in Nephrological Patients

• Sponsor: Waid City Hospital, Zurich (Other)
• Overall Status: Recruiting
• CT.gov ID: NCT02663336
• Collaborator: (none)
• Enrollment: 100
• Location: 1
• Duration (Months): 95
• Patients Per Site Per Month: 1.1

Study Details

Study Description

Brief Summary

The purpose of this study is to determine the percentage of patients with masked hypertension in a population with chronic kidney disease. The investigators goal is to register prospectively ambulatory blood pressure measurement results of patients of a nephrological outpatient clinic with normal office blood pressure to finally find the percentage of masked hypertension in this population.

Condition or Disease	Intervention/Treatment	Phase
Masked Hypertension	Other: Comparison ABPM with OBPM

Study Design

• Study Type: Observational
• Anticipated Enrollment: 100 participants
• Observational Model: Cohort
• Time Perspective: Prospective
• Official Title: Prevalence of Masked Hypertension in Nephrological Patients
• Study Start Date: Dec 1, 2015
• Anticipated Primary Completion Date: Jan 1, 2023
• Anticipated Study Completion Date: Nov 1, 2023

Arms and Interventions

Arm	Intervention/Treatment
CKD patients Patients with chronic kidney disease, with diagnosed arterial hypertension and normal blood pressure during office blood pressure measurement. Comparison of ambulatory blood pressure (ABPM) with office blood pressure measurements (OBPM).	Other: Comparison ABPM with OBPM; No interventions

Outcome Measures

Primary Outcome Measures

1. Number of participants with uncontrolled masked hypertension assessed by comparison of ambulatory blood pressure with office blood pressure [2 years]

Eligibility Criteria

Criteria

• Ages Eligible for Study: 20 Years to 90 Years
• Sexes Eligible for Study: All
• Accepts Healthy Volunteers: No

Inclusion Criteria:

• Age: 20-90 years

• Known arterial hypertension and antihypertensive medical treatment

• Office blood pressure < 140 mmHg systolic and <90 mmHg diastolic

Exclusion Criteria:

• Age <20 or >90 years

Contacts and Locations

Locations

	Site	City	State	Country	Postal Code
1	Stadtspital Waid Zurich	Zurich		Switzerland	8037

Sponsors and Collaborators

• Waid City Hospital, Zurich

Investigators

• Principal Investigator: Andreas Schleich, Stadtspital Waid Zurich Switzerland

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.

• Responsible Party: Waid City Hospital, Zurich
• ClinicalTrials.gov Identifier: NCT02663336
• Other Study ID Numbers: WaidBP16
• First Posted: Jan 26, 2016
• Last Update Posted: Oct 28, 2021
• Last Verified: Oct 1, 2021

• Keywords provided by Waid City Hospital, Zurich: masked hypertension, chronic kidney disease
• Additional relevant MeSH terms: Hypertension; Masked Hypertension

Study Results

No Results Posted as of Oct 28, 2021